Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
Maria Palasis
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
chronic rhinosinusitis
nasal drug delivery |
| gptkbp:foundedYear |
2005
|
| gptkbp:hasCompany |
Lyra Therapeutics, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Watertown,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
LYBR
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:LYBR
|
| gptkbp:website |
https://www.lyratherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Berane_Airport
|
| gptkbp:bfsLayer |
8
|